Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Use of Oral Lacosamide in Pediatric Epilepsy
NCT04627285Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2020
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started Dec 2020; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04627285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04627285.